Drug Trial Radar · NCT07456800
PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
116
Actual
Start
Jul 12, 2021
Primary completion
Jan 1, 2022
Study completion Jan 20, 2022
Sponsor
- Lead sponsor
- PureTechIndustry
- Sponsor type
- Industry
- First posted
- Mar 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A three-part, randomized, double-blind study in healthy older adults to identify a dose of deupirfenidone for further clinical study.
Conditions
- Pharmacokinetic Analysis
Interventions
DeupirfenidoneDrug
Swedish orange capsule
Pirfenidone (PFD)Drug
Swedish orange capsule
PlaceboDrug
Swedish orange capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Cmax of BID deupirfenidone versus TID pirfenidoneTime frame: 14 days
- Part 2: Cmax of TID deupirfenidone versus TID pirfenidoneTime frame: 14 days
- Part 3: Cmax of TID deupirfenidone versus placeboTime frame: 6 days
- Part 1: AUC of BID deupirfenidone versus TID pirfenidoneTime frame: 14 Days
- Part 1: Tmax of BID deupirfenidone versus TID pirfenidoneTime frame: 14 Days
- Part 2: AUC of TID deupirfenidone versus TID pirfenidoneTime frame: 14 Days
- Part 2: Tmax of TID deupirfenidone versus TID pirfenidoneTime frame: 14 Days
- Part 3: AUC of TID deupirfenidone versus placeboTime frame: 6 Days
- Part 3: PK profile of TID deupirfenidone versus placeboTime frame: 6 Days
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Collaborative Neuroscience Network, LLC.
Long Beach, California
Accel Research Sites
Lake Mary, Florida
Hassman Research
Berlin, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.